東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Preventive and predictive genetics =...

Grech, Godfrey.

Linked to FindBook

Google Book

Amazon

博客來

Preventive and predictive genetics = towards personalised medicine /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Preventive and predictive genetics/ edited by Godfrey Grech, Iris Grossman.
Reminder of title:	towards personalised medicine /
other author:	Grech, Godfrey.
Published:	Cham :Springer International Publishing : : 2015.,
Description:	xx, 378 p. :ill., digital ;24 cm.
[NT 15003449]:	Introduction -- Preventive and Predictive Genetics: A perspective -- Roadmap to Drug Development Enabled by Pharmacogenetics -- Preventative and Predictive Genetics: Towards Personalised Medicine -- Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality -- Pharmacogenetics of Adverse Drug Reactions -- Pharmacogenomics for haemoglobinopathies therapeutics -- Pharmacogenetics of Neurodegenerative Disorders -- Pharmacogenetics of asthma -- Pharmacogenetics and antineoplastic therapies -- Pharmacogenetics of coumarin anticoagulant therapy -- Implementation of Genomic Medicine: tools and challenges -- Ethical Considerations in the Genomic Era -- Index.
Contained By:	Springer eBooks
Subject:	Pharmacogenetics. -
Online resource:	http://dx.doi.org/10.1007/978-3-319-15344-5
ISBN:	9783319153445 (electronic bk.)

Preventive and predictive genetics = towards personalised medicine /
Preventive and predictive geneticstowards personalised medicine /[electronic resource] :edited by Godfrey Grech, Iris Grossman. - Cham :Springer International Publishing :2015. - xx, 378 p. :ill., digital ;24 cm. - Advances in predictive, preventive and personalised medicine,v.92211-3495 ;. - Advances in predictive, preventive and personalised medicine ;v.1..

Introduction -- Preventive and Predictive Genetics: A perspective -- Roadmap to Drug Development Enabled by Pharmacogenetics -- Preventative and Predictive Genetics: Towards Personalised Medicine -- Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality -- Pharmacogenetics of Adverse Drug Reactions -- Pharmacogenomics for haemoglobinopathies therapeutics -- Pharmacogenetics of Neurodegenerative Disorders -- Pharmacogenetics of asthma -- Pharmacogenetics and antineoplastic therapies -- Pharmacogenetics of coumarin anticoagulant therapy -- Implementation of Genomic Medicine: tools and challenges -- Ethical Considerations in the Genomic Era -- Index.

Traditionally, medical research comprised of the identification of the pathological causes of a disease, its epidemiology and empirical investigation of treatment response. Intensive genetic research, marked by the completion of the human genome project in 2003, heralded a new era in medical research. While epidemiology and gross pathology are still mainstay useful tools, genetics and genomics have gradually been shown to increase the resolution of drug response research, showing great potential in also informing and identifying the role of genes and their encoded products in the pathophysiology of diseases. This information is already being applied in the prevention of illness, effective early diagnosis, better risk assessment (prognosis), as well as targeted effective and safe treatment allocation (prediction and monitoring) Genetic testing and genomics support personalised medicine by translating genome-based knowledge into clinical practice, offering enhanced benefit for patients and health-care systems at large. Current routine practice for diagnosing and treating patients is conducted by correlating parameters such as age, gender and weight with risks and expected treatment outcomes. In the new era of personalised medicine the healthcare provider is equipped with improved ability to prevent, diagnose, treat and predict outcomes on the basis of complex information sources, including genetic and genomic data. Targeted therapy and reliable prediction of expected outcomes offer patients access to better healthcare management, by way of identifying the therapies effective for the relevant patient group, avoiding prescription of unnecessary treatment and reducing the likelihood of developing adverse drug reactions.

ISBN: 9783319153445 (electronic bk.)

Standard No.: 10.1007/978-3-319-15344-5doiSubjects--Topical Terms:

864768
Pharmacogenetics.

LC Class. No.: RM301.3.G45

Dewey Class. No.: 615.7

Preventive and predictive genetics = towards personalised medicine /
LDR:03541nam a2200349 a 4500 001 2007845
003 DE-He213
005 20160125103427.0
006 m d
007 cr nn 008maaau
008 160219s2015 gw s 0 eng d
020 $a 9783319153445 (electronic bk.)
020 $a 9783319153438 (paper)
024 7 $a 10.1007/978-3-319-15344-5 $2 doi
035 $a 978-3-319-15344-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RM301.3.G45
072 7 $a MBGR $2 bicssc
072 7 $a PSD $2 bicssc
072 7 $a SCI049000 $2 bisacsh
072 7 $a MED067000 $2 bisacsh
082 0 4 $a 615.7 $2 23
090 $a RM301.3.G45 $b P944 2015
245 0 0 $a Preventive and predictive genetics $h [electronic resource] : $b towards personalised medicine / $c edited by Godfrey Grech, Iris Grossman.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2015.
300 $a xx, 378 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in predictive, preventive and personalised medicine, $x 2211-3495 ; $v v.9
505 0 $a Introduction -- Preventive and Predictive Genetics: A perspective -- Roadmap to Drug Development Enabled by Pharmacogenetics -- Preventative and Predictive Genetics: Towards Personalised Medicine -- Pharmacokinetics and Pharmacogenetics: bringing the magic bullet closer to reality -- Pharmacogenetics of Adverse Drug Reactions -- Pharmacogenomics for haemoglobinopathies therapeutics -- Pharmacogenetics of Neurodegenerative Disorders -- Pharmacogenetics of asthma -- Pharmacogenetics and antineoplastic therapies -- Pharmacogenetics of coumarin anticoagulant therapy -- Implementation of Genomic Medicine: tools and challenges -- Ethical Considerations in the Genomic Era -- Index.
520 $a Traditionally, medical research comprised of the identification of the pathological causes of a disease, its epidemiology and empirical investigation of treatment response. Intensive genetic research, marked by the completion of the human genome project in 2003, heralded a new era in medical research. While epidemiology and gross pathology are still mainstay useful tools, genetics and genomics have gradually been shown to increase the resolution of drug response research, showing great potential in also informing and identifying the role of genes and their encoded products in the pathophysiology of diseases. This information is already being applied in the prevention of illness, effective early diagnosis, better risk assessment (prognosis), as well as targeted effective and safe treatment allocation (prediction and monitoring) Genetic testing and genomics support personalised medicine by translating genome-based knowledge into clinical practice, offering enhanced benefit for patients and health-care systems at large. Current routine practice for diagnosing and treating patients is conducted by correlating parameters such as age, gender and weight with risks and expected treatment outcomes. In the new era of personalised medicine the healthcare provider is equipped with improved ability to prevent, diagnose, treat and predict outcomes on the basis of complex information sources, including genetic and genomic data. Targeted therapy and reliable prediction of expected outcomes offer patients access to better healthcare management, by way of identifying the therapies effective for the relevant patient group, avoiding prescription of unnecessary treatment and reducing the likelihood of developing adverse drug reactions.
650 0 $a Pharmacogenetics. $3 864768
650 0 $a Genetic screening. $3 600517
650 0 $a Personalized medicine. $3 2134267
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Molecular Medicine. $3 890952
650 2 4 $a Medical Education. $3 898572
650 2 4 $a Systems Biology. $3 928020
650 2 4 $a Human Genetics. $3 891169
650 2 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Drug Resistance. $3 836316
700 1 $a Grech, Godfrey. $3 2156886
700 1 $a Grossman, Iris. $3 2156887
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in predictive, preventive and personalised medicine ; $v v.1. $3 1621245
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-15344-5
950 $a Medicine (Springer-11650)